Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$77.6M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$71.2M |
| 3 |
Microsoft
MSFT
|
+$70M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$67.5M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$61.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$34.9M |
| 2 |
Colgate-Palmolive
CL
|
+$33.1M |
| 3 |
Phillips 66
PSX
|
+$31.7M |
| 4 |
S&P Global
SPGI
|
+$27.7M |
| 5 |
VMW
VMware, Inc
VMW
|
+$22.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.4% |
| 2 | Healthcare | 9.43% |
| 3 | Industrials | 9.12% |
| 4 | Consumer Discretionary | 8.48% |
| 5 | Financials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
CALL
Paychex
PAYX
$44.3B
| $582K | 0.01% |
5,200
-5,500
| -51% | -$602K |
|
1627
PUT
Target
TGT
$74B
| $580K | 0.01% |
+4,400
| New | +$653K |
|
1628
TE Connectivity
TEL
$57.8B
| $580K | 0.01% |
4,138
-83,255
| -95% | -$10.5M |
|
|
NXRT
1629
NexPoint Residential Trust
NXRT
$627M
| $580K | 0.01% |
12,751
-10,723
| -46% | -$462K |
|
|
VERV
1630
DELISTED
Verve Therapeutics
VERV
| $578K | 0.01% |
30,843
-8,931
| -22% | -$149K |
|
1631
PUT
Corning
GLW
$127B
| $578K | 0.01% |
16,500
-8,400
| -34% | -$276K |
|
1632
Twist Bioscience
TWST
$9.67B
| $576K | 0.01% |
28,152
+1,783
| +7% | +$26.7K |
|
1633
Kirby Corp
KEX
$7.3B
| $576K | 0.01% |
+7,480
| New | +$538K |
|
1634
Vitesse Energy
VTS
$713M
| $574K | 0.01% |
+25,633
| New | +$535K |
|
1635
Mesa Laboratories
MLAB
$710M
| $572K | 0.01% |
+4,455
| New | +$679K |
|
|
1636
PUT
Phillips 66
PSX
$95.9B
| $572K | 0.01% |
6,000
+200
| +3% | +$19.4K |
|
1637
Golar LNG
GLNG
$5.26B
| $571K | 0.01% |
+28,296
| New | +$608K |
|
1638
PUT
Kinder Morgan
KMI
$69.3B
| $570K | 0.01% |
+33,100
| New | +$562K |
|
|
DHC
1639
Diversified Healthcare Trust
DHC
$1.95B
| $570K | 0.01% |
253,292
-79,982
| -24% | -$115K |
|
1640
NovaGold Resources
NG
$4.25B
| $569K | 0.01% |
+142,549
| New | +$766K |
|
1641
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.68B
| $568K | 0.01% |
6,171
+1,962
| +47% | +$180K |
|
1642
PUT
CSX Corp
CSX
$95.1B
| $566K | 0.01% |
16,600
-11,400
| -41% | -$361K |
|
1643
Constellium
CSTM
$3.68B
| $566K | 0.01% |
32,890
+8,642
| +36% | +$133K |
|
1644
CALL
DexCom
DXCM
$34.2B
| $565K | 0.01% |
+4,400
| New | +$532K |
|
1645
TTM Technologies
TTMI
$11.8B
| $565K | 0.01% |
40,676
+13,807
| +51% | +$178K |
|
1646
CALL
Ulta Beauty
ULTA
$22.8B
| $565K | 0.01% |
+1,200
| New | +$588K |
|
|
SCS
1647
DELISTED
Steelcase
SCS
| $565K | 0.01% |
73,231
-206,645
| -74% | -$1.56M |
|
|
LICY
1648
DELISTED
Li-Cycle Holdings Corp.
LICY
| $564K | 0.01% |
12,709
+7,300
| +135% | +$298K |
|
1649
Federated Hermes
FHI
$4.87B
| $562K | 0.01% |
+15,674
| New | +$606K |
|
1650
PUT
Starwood Property Trust
STWD
$6.01B
| $561K | 0.01% |
+28,900
| New | +$514K |
|
Similar funds
Paul Tudor Jones's Q2 2023 Portfolio in Review
As of Q2 2023, Paul Tudor Jones held 3,099 positions worth $8.38B, up 30% from $6.46B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Paul Tudor Jones deployed $1.58B of net new capital in Q2 2023, opening 763 new positions and adding to 795 existing holdings. Its largest new stake was Seagen Inc. Common Stock: 340,004 shares worth $65.4M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Colgate-Palmolive, an estimated $33.1M trimmed.
- Paul Tudor Jones's largest Q2 2023 buy was Seagen Inc. Common Stock: 340,004 shares worth $65.4M.
- Paul Tudor Jones added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $77.6M increase.
- Paul Tudor Jones's biggest Q2 2023 reduction was Colgate-Palmolive, cutting an estimated $33.1M.
- Paul Tudor Jones fully exited Johnson & Johnson in Q2 2023, selling an estimated $34.9M.
- Paul Tudor Jones's ten largest holdings make up 13% of its $8.38B portfolio in Q2 2023.
- Paul Tudor Jones opened 763 new positions and closed 736 in Q2 2023.
- Paul Tudor Jones's portfolio value rose 30% quarter-over-quarter to $8.38B.
Based on Tudor Investment Corp's 13F filing for Q2 2023, filed 14 Aug 2023.